News Agency
The Times

Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management

  • Written by PR Newswire

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant in Hong Kong, the first market in Asia, a calcitonin gene-related peptide (CGRP) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine in Hong Kong[3] and it is one of the leading causes of disability...

Read more: Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion